XML 34 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Compensation Plans (Stock Appreciation Rights) (Details) (USD $)
6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2012
Sep. 30, 2012
Dec. 31, 2012
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]        
Number of shares vested and expected to vest     2,867,115  
Stock Appreciation Rights (SARs) [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period   3 years    
Maximum number of shares to be issued     453,465  
Weighted average grant-date fair value, granted   $ 0.68    
Expected volatility 71.00%      
Expected life from grant date     4 years 6 months  
Expected dividend yield 0.00%      
Risk-free interest rate 0.61%      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]        
Number of shares granted     1,446,802  
Number of shares exercised     0  
Number of shares canceled and expired     (25,851)  
Number of shares outstanding at end of period     1,420,951 0
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward]        
Weighted average exercise price granted     $ 3.53  
Weighted average exercise price exercised     $ 0.00  
Weighted average exercise price canceled and expired     $ 3.53  
Weighted average exercise price outstanding at end of period     $ 3.53 $ 0.00
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]        
Weighted average remaining life, outstanding     6 years 1 month 1 day  
Intrinsic value outstanding     $ 0  
Number of shares vested and expected to vest     1,359,167  
Weighted average exercise price, vested and expected to vest     $ 3.53  
Weighted average remaining life, vested and expected to vest     6 years 1 month 1 day  
Intrinsic value, vested and expected to vest     $ 0  
Number of shares exercisable     0  
Weighted average exercise price, exercisable     $ 0.00  
Weighted average remaining life, exercisable     0 years  
Intrinsic value, exercisable     0  
Unrecognized stock-based compensation cost     $ 666,000  
Weighted average remaining requisite service period (in years)     2 years 1 month 1 day  
Stock Appreciation Rights (SARs) [Member] | Maximum [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Expiration period   7 years